Viking Financial Statements From 2010 to 2024

VKTX Stock  USD 82.00  1.34  1.61%   
Viking Therapeutics financial statements provide useful quarterly and yearly information to potential Viking Therapeutics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Viking Therapeutics financial statements helps investors assess Viking Therapeutics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Viking Therapeutics' valuation are summarized below:
Market Capitalization
8.8 B
Earnings Share
(0.91)
We have found one hundred fourteen available fundamental trend indicators for Viking Therapeutics, which can be analyzed and compared to other ratios and to its competition. All investors should make sure to double-check all of Viking Therapeutics current market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road.
Check Viking Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Viking main balance sheet or income statement drivers, such as Depreciation And Amortization of 277.4 K, Interest Expense of 83.6 K or Selling General Administrative of 38.9 M, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 9.0E-4 or Price Book Value Ratio of 5.29. Viking financial statements analysis is a perfect complement when working with Viking Therapeutics Valuation or Volatility modules.
  
This module can also supplement Viking Therapeutics' financial leverage analysis and stock options assessment as well as various Viking Therapeutics Technical models . Check out the analysis of Viking Therapeutics Correlation against competitors.
For more information on how to buy Viking Stock please use our How to Invest in Viking Therapeutics guide.

Viking Therapeutics Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Short and Long Term Debt Total1.5 M1.3 M1.1 M
Pretty Stable
Other Current Liabilities11.9 M11.3 M4.2 M
Slightly volatile
Total Current Liabilities10.4 M19.1 M8.2 M
Slightly volatile
Accounts Payable7.9 M7.5 M2.5 M
Slightly volatile
Common Stock Total Equity5831.1 K511
Slightly volatile
Non Current Liabilities Total1.1 M936 K1.2 M
Very volatile
Other Stockholder Equity763.1 M726.8 M252.7 M
Slightly volatile
Total Liabilities11.3 M20.1 MM
Slightly volatile
Common Stock6261.1 K513
Slightly volatile
Total Assets386.9 M368.5 M135.6 M
Slightly volatile
Other Liabilities10.3 K10.8 K291.6 K
Pretty Stable
Cash58.3 M55.5 M16.9 M
Slightly volatile
Non Current Assets Total755.8 K1.3 M554.4 K
Slightly volatile
Non Currrent Assets Other132.1 K139 K280.3 K
Pretty Stable
Cash And Short Term Investments380.2 M362.1 M131.6 M
Slightly volatile
Common Stock Shares Outstanding50.8 M94.3 M38.1 M
Slightly volatile
Liabilities And Stockholders Equity386.9 M368.5 M135.6 M
Slightly volatile
Total Current Assets385.6 M367.2 M135 M
Slightly volatile
Short Term Debt307.8 K324 K750.8 K
Very volatile
Current Deferred Revenue1.9 M2.1 M8.1 M
Slightly volatile
Other Assets60.7 K63.9 K896.8 K
Slightly volatile
Other Current Assets3.7 M2.5 M2.5 M
Slightly volatile
Deferred Long Term Liabilities32.5 K34.2 K802 K
Slightly volatile
Short and Long Term Debt2.5 MM2.3 M
Slightly volatile
Short Term Investments171 M306.6 M109.1 M
Slightly volatile
Long Term Debt Total1.7 M1.9 M2.1 M
Slightly volatile
Capital Surpluse317.3 M512.1 M227.2 M
Slightly volatile
Additional Paid In Capital62.8 M108.5 M57.2 M
Slightly volatile
Non Current Liabilities Other789.5 K1.1 M1.4 M
Slightly volatile
Net Invested Capital240.7 M348.4 M126.1 M
Slightly volatile
Net Working Capital239.9 M348.1 M123.9 M
Slightly volatile
Capital Stock800900980
Slightly volatile
Property Plant And Equipment Net767.4 K1.1 M642.5 K
Pretty Stable
Capital Lease Obligations852.3 K1.3 M712.3 K
Pretty Stable
Property Plant And Equipment Gross767.4 K1.1 M642.5 K
Pretty Stable

Viking Therapeutics Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative38.9 M37 M9.8 M
Slightly volatile
Other Operating Expenses105.9 M100.8 M33.5 M
Slightly volatile
Research Development67 M63.8 M23.8 M
Slightly volatile
Total Operating Expenses105.9 M100.8 M33.5 M
Slightly volatile
Interest Income11.6 M11 M3.1 M
Slightly volatile
Reconciled Depreciation311.1 K290 K271 K
Slightly volatile
Selling And Marketing Expenses233.6 K262.8 K286.2 K
Slightly volatile

Viking Therapeutics Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Total Cash From Financing Activities284.9 M271.4 M61.8 M
Slightly volatile
End Period Cash Flow58.3 M55.5 M16.9 M
Slightly volatile
Stock Based Compensation17.6 M16.8 M4.5 M
Slightly volatile
Begin Period Cash Flow38.5 M36.6 M11.9 M
Slightly volatile
Depreciation543.6 K292 K638.1 K
Pretty Stable

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Dividend Yield9.0E-40.0010.0011
Slightly volatile
Days Of Payables Outstanding10.1 K9.6 K4.8 K
Slightly volatile
Ebt Per Ebit1.190.85191.1587
Slightly volatile
Payables Turnover0.03690.03890.0969
Slightly volatile
Cash Per Share4.033.83771.9439
Slightly volatile
Quick Ratio13.7818.922313.8294
Slightly volatile
Net Income Per E B T0.770.880.9101
Pretty Stable
Cash Ratio1.462.90131.7126
Slightly volatile
Current Ratio14.119.191314.1519
Slightly volatile
Debt Ratio0.00320.00340.4826
Slightly volatile

Viking Fundamental Market Drivers

Cash And Short Term Investments362.1 M

Viking Upcoming Events

14th of February 2024
Upcoming Quarterly Report
View
24th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
14th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Viking Therapeutics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Viking Therapeutics income statement, its balance sheet, and the statement of cash flows. Viking Therapeutics investors use historical funamental indicators, such as Viking Therapeutics's revenue or net income, to determine how well the company is positioned to perform in the future. Although Viking Therapeutics investors may use each financial statement separately, they are all related. The changes in Viking Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Viking Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Viking Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Viking Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Current Deferred Revenue2.1 M1.9 M
Total Revenue10.7 K0.0
Cost Of Revenue292 K155.8 K
Ebit Per Revenue 0.00  0.00 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Viking Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Viking Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Viking Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Viking Therapeutics Stock:
Check out the analysis of Viking Therapeutics Correlation against competitors.
For more information on how to buy Viking Stock please use our How to Invest in Viking Therapeutics guide.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for Viking Stock analysis

When running Viking Therapeutics' price analysis, check to measure Viking Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viking Therapeutics is operating at the current time. Most of Viking Therapeutics' value examination focuses on studying past and present price action to predict the probability of Viking Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viking Therapeutics' price. Additionally, you may evaluate how the addition of Viking Therapeutics to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Commodity Directory
Find actively traded commodities issued by global exchanges
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Global Correlations
Find global opportunities by holding instruments from different markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Is Viking Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Viking Therapeutics. If investors know Viking will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Viking Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.91)
Return On Assets
(0.23)
Return On Equity
(0.35)
The market value of Viking Therapeutics is measured differently than its book value, which is the value of Viking that is recorded on the company's balance sheet. Investors also form their own opinion of Viking Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Viking Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Viking Therapeutics' market value can be influenced by many factors that don't directly affect Viking Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Viking Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Viking Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viking Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.